These patient group direction (PGD) templates support the supply of:
- oseltamivir 75mg and 30mg capsules for post exposure prophylaxis (PEP) of influenza
- zanamivir inhalation powder for PEP of influenza
- oseltamivir 75mg and 30mg capsules for the treatment of influenza
- zanamivir inhalation powder for the treatment of influenza
They all apply to adult residents and staff of care homes (with or without nursing) and are valid from 7 January 2016 until 7 January 2019.
The PGD templates require further authorisation by a clinical governance or patient safety lead, who has designated responsibility for signing PGDs, so the documents meet legal requirements for a PGD. The PGDs are not legal or valid without this local, formal authorisation.
Adoption and governance of the use of these PGDs is the responsibility of the authorising commissioning body and providers.
Provider organisations and health professionals should check they are working to the current PGD versions and only work to a legally authorised PGD from their commissioning body.